Harvett, you said "When HGR first tool over SBN when the product was new and exciting the share price was 0.014 the same as today."
This is just not true, wasn't the share price about 40c back then in June 2006? And SBN had about 160m shares on issue, so roughly a $60m market cap?
The price decreased rapidly in 2007/2008 then in 2012 it was trading with 2.3 billion shares on issue before a 14:1 consolidation occurred. Is this correct?
So in 2006 it had 160m shares on issue and traded between 30c and 60c. Today, recapitalised and with a new board it has 330m shares on issue but is trading at 1.4c.
Regardless of Oraline success/failure, they are looking at other transactions anyway.
I guess to see the potential value you have to believe what the new board has said and what they are doing. I think, at least in the short term, there is room for various announcements that will drive the price higher, even if it is a spike.
Recently it's gone from 0.8c to 1.4c, and now the volume is increasing and news flow (from Oraline and other transactions) is definitely not over imo.
- Forums
- ASX - By Stock
- small cap bio, massive potential only $4m m/c
Harvett, you said "When HGR first tool over SBN when the product...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online